Key result
Multidisciplinary studies of ventricular voltage-gated ion channels drive therapeutic target discovery and drug safety evaluation.
Why the study?
Inherited or acquired alterations in ventricular voltage-gated ion channels (VGICs) and drug-related side effects can cause life-threatening arrhythmias or sudden cardiac death, making them critical targets in drug discovery and safety evaluation.
Design
Review
Authors
Loading...
May inform safer cardiac drug design targeting ion channels; leaves open clinical efficacy until prospective trials.
This review highlights the importance of ventricular voltage-gated ion channels as targets in drug discovery and safety studies related to cardiac disease.
Chen et al. (2021) conducted a review in Cardiac arrhythmias and inherited cardiac diseases. Voltage-gated ion channels (VGICs) evaluation was evaluated. Multidisciplinary studies on ventricular voltage-gated ion channels are essential for discovering potential therapeutic targets, understanding pathological mechanisms, and evaluating drug safety.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: